Направо към основното съдържание
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
Новинарска статия12 Hоември 2018 г.Европейска агенция по лекарстватаВреме за четене 1 мин

Use of patient disease registries for regulatory purposes

The EMA cross-committee task force on registries has published a discussion paper on methodological and operational considerations in the use of patient disease registries for regulatory purposes. As explained in the document, interested parties are invited to send their comments and suggestions by 30/06/2019. Responses will be considered in the finalisation of the document in consultation with the relevant EMA committees by the end of 2019.

 

Related information:

» Patient registries (EMA website) 

» Discussion paper: Use of patient disease registries for regulatory purposes – methodological and operational considerations

Данни

Дата на публикуване
12 Hоември 2018 г.
Автор
Европейска агенция по лекарствата